Early stage medical device company Centerline Biomedical, which developed a 3D vascular navigation system to help surgeons to carry out procedures has raised $1.7 million, according to a company statement.
The system is akin to GPS for vascular surgery. The surgical platform was developed by Cleveland Clinic surgeons from the Heart & Vascular Institute and researchers at Lerner Research Institute. It is designed to be used for procedures that currently require X-ray technology to help surgeons guide their instruments in the bodies of vascular disease patients. These procedures can take several hours and risk exposing surgical teams to radiation and can take longer because of navigation challenges to surgeons.
Dr. Matthew Eagleton, Chair of the Medical Advisory Board for Centerline, said in a statement:
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
“The opportunity to positively impact a growing number of patients and providers alike is significant…Centerline’s platform technology solves an immediate need and has the ability to transform many vascular and non-vascular procedures by reducing radiation, improving outcomes and saving costs.”
Centerline Biomedical, led by CEO William Fuller, is a Cleveland Clinic spin-out and got its start last year. It was formed through Cleveland Clinic’s commercialization arm – Cleveland Clinic Innovations. Ohio BioValidation Fund, a state-supported early stage venture fund, has previously backed the company. Fuller was the former CEO-in-residence of Cleveland’s BioEnterprise life sciences accelerator.
